Lycored expanded its tomato-based lycopene production following a three-year multi-million-dollar investment in new lines, equipment, and process and supply optimization strategies.
Photo © iStockphoto.com/fotokostic
Lycored expanded its tomato-based lycopene production following a three-year multi-million-dollar investment in new lines, equipment, and process and supply optimization strategies. Central to this expansion is its carotenoid formulation capabilities, driven by its new formulation facility in Branchburg, NJ, which will increase its current formulation capacity and support expansion and supply into additional markets.
“The expansion of our lycopene production follows a period of strategic equipment investments and improvements in tomato usage during key harvest periods,” said David Hebel, senior vice president of operations at Lycored, in a press release. “These changes will ensure that we have the expertise and the capacity to meet the needs of our customers across the health, food, and beauty ingredient industries.”
To provide higher product availability at different times of the year, the company also plans to further expand its seasonal capacity by working with a third party in the Southern hemisphere.
Lycored’s growing capacity will harvest possibilities in health and food applications, including plant-based products and beauty-from-within formulations.
“Demand for ingestible skincare ingredients is higher than ever and continues to grow as clean label and minimal waste become prerequisite,” Hebel said. “As manufacturers and developers look to capitalize on these trends, we are ready with our portfolio to support their projects.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.